ReviewFish physiology and biochemistry2025
All that glitters is not gold: towards the standardization of experimental trials assessing functional feeds with immunomodulatory properties.
Review in Fish physiology and biochemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Functional feeds designed to enhance the host's immune response and improve disease resistance are among the most popular strategies to mitigate the impact of infectious diseases and abiotic stressors in aquaculture. While reviewing the current scientific literature on this issue, we have detected that there is a need to standardize the evaluation criteria for feed additives with immunostimulant properties in terms of the duration of the trial and selection of key end-points related to the expected effect of the dietary intervention. The evaluation of the disease protective role of a feed additive should not be based only on end-points from cellular and immune biomarkers, but it should also be complemented with end-points based on survival data of specimens exposed to an in vivo infective challenge. We also recommend giving special consideration to the basal diet used in these studies since the inclusion of certain ingredients may have confounding results with those expected from the additive or functional ingredient of interest. Regardless of the in vivo challenge model selected (balneation, cohabitation, intraperitoneal injection, or oral/anal intubation), abiotic factors such as temperature, water flow, light, and water quality strongly influence the development of disease and must be also taken into consideration when designing experimental challenge models. Thus, it is of paramount importance to standardize the studies testing the efficacy of functional diets designed to protect the host from infectious agents and to assist in harmonizing the interpretation of their results.
Indexed as
Identifiers
41091248What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.